Beckman Coulter's DxI 9000 Immunoassay Analyzer with Increased Assay Development Sensitivity Makes First North American Appearance at 2023 AACC

/PRNewswire/ -- Beckman Coulter, a clinical diagnostics leader, today revealed for the first time in North America the DxI 9000 Access Immunoassay Analyzer,...

Related Keywords

Ireland ,United States ,America ,Beckman Coulter ,Ray Divilley ,Prnewswire Beckman Coulter ,Zivjena Vucetic ,Mayo University Hospital ,Beckman Coulter Inc ,Facebook ,Danaher Corporation ,Twitter ,Scientific Affairs ,Fujirebio Holdings Inc ,Linkedin ,Precisionvision Technology ,North America ,Immunoassay Analyzer ,Chief Medical Officer ,Senior Vice President ,Beckman Coulter Diagnostics ,Vitro Diagnostic ,Access Family Immunoassay ,Goki Ishikawa ,Fujirebio Holdings ,Daily Maintenance ,Zerodaily Maintenance ,Relentlessly Reimagine Healthcare ,Zone Diagnosis ,Nc ,